AstraZeneca and CSPC join forces to combat high cholesterol
In a move to strengthen its cardiovascular treatment portfolio, AstraZeneca announced a partnership with CSPC Pharmaceutical Group that could reach a staggering $1.92 billion. This [more…]
In a move to strengthen its cardiovascular treatment portfolio, AstraZeneca announced a partnership with CSPC Pharmaceutical Group that could reach a staggering $1.92 billion. This [more…]
Medical experts in Hong Kong recommend that residents receive a third-generation COVID-19 vaccine specifically targeting the XBB variant to enhance protection, especially in anticipation of [more…]